Generali Asset Management SPA SGR

Position in NBIX — Neurocrine Biosciences Inc

CIK 2046751 TRIESTE, L6

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$2,936,809

-$429,148 QoQ

Shares Held

17,425

-31.8% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#265

of 768 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 19% Shared 0% None 81%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Generali Asset Management SPA SGR holds $7,610,582 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (38.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	57,138	$4,105,936
2	NBIX	Neurocrine Biosciences Inc This page	17,425	$2,936,809
3	UTHR	UNITED THERAPEUTICS Corp	1,048	$567,837

All Filings in NBIX

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,936,809	17,425	-31.8%	Shares	Sole	2026-07-30
2026-03-31	$3,365,957	25,550	+12.5%	Shares	Sole	2026-05-05
2025-12-31	$3,219,966	22,703	-13.9%	Shares	Sole	2026-02-03
2025-09-30	$3,700,416	26,360	-9.3%	Shares	Sole	2025-10-21
2025-06-30	$3,653,179	29,065	+296.6%	Shares	Sole	2025-07-28
2025-03-31	$810,587	7,329	-69.0%	Shares	Sole	2025-05-15
2024-12-31	$3,222,082	23,605	—	Shares	Sole	2025-05-29
No filing history on record for this holder in this stock.